Merit Medical Systems, Inc. MMSI
Set alert
At close · Nov 2
After hours · Nov 2, 4:00 PM ET
- YTD
- -4.35%
- 1 year
- -3.69%
- Open
- 86.26
- Prev close
- 86.24
- Mkt cap
- 5.05B
- Vol
- 1.20M
- Avg vol
- 755.20K
- EPS
- 2.67
- P/E
- 31.58
- Div yield
- 0.00%
More statistics
- Low
- 83.72
- High
- 86.34
- Forward P/E
- 18.06
- Beta
- 0.55
- Short ratio
- 6.23
- Inst. own
- 108.08%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 23, 2027
- 50-d avg
- 88.60
- 200-d avg
- 76.94
- 1y target
- 107.00
5Y chart
Events in this range
- Oct 30, 2025Earnings: 0.92; estimate 0.82; surprise 12.2%
- Feb 24, 2026Earnings: 1.04; estimate 0.96; surprise 8.33%
- Apr 30, 2026Earnings: 0.94; estimate 0.84; surprise 11.9%
- Jul 30, 2026Earnings: 1.19; estimate 0.959; surprise 24.09%
- Oct 27, 2026Rating: Freedom Capital Markets · — → Hold
- Oct 29, 2026Earnings: 1.12; estimate 1.04; surprise 7.69%
- Oct 30, 2026Rating: BTIG · Buy → Buy
- Oct 30, 2026Rating: Needham · Buy → Buy
- Oct 30, 2026Rating: Wells Fargo · Equal-Weight → Equal-Weight
- Oct 30, 2026Rating: JP Morgan · Overweight → Overweight
- Oct 30, 2026Rating: Canaccord Genuity · Buy → Buy
Signals (86)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 2, 2026 | 22 hours ago |
| SMA: Bearish | Oct 26, 2026 | 1 week ago |
| SMA: Bullish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| RSI: Overbought | Aug 3, 2026 | 3 months ago |
| SMA: Bullish | Jul 6, 2026 | 3 months ago |
| SMA: Bullish | Jun 8, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 8, 2026 | 4 months ago |
| RSI: Oversold | Apr 27, 2026 | 6 months ago |
| RSI: Oversold | Mar 2, 2026 | 8 months ago |
| MACD: Sell Signal | Jan 26, 2026 | 9 months ago |
| SMA: Bearish | Dec 29, 2025 | 10 months ago |
| SMA: Bearish | Dec 29, 2025 | 10 months ago |
| SMA: Bullish | Dec 15, 2025 | 10 months ago |
| SMA: Bullish | Dec 8, 2025 | 10 months ago |
| SMA: Bearish | Dec 1, 2025 | 11 months ago |
| SMA: Bullish | Oct 27, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 27, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 15, 2025 | 1 year ago |
| SMA: Bearish | Sep 8, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 1, 2025 | 1 year ago |
| SMA: Bullish | Aug 18, 2025 | 1 year ago |
| SMA: Bearish | Jun 9, 2025 | 1 year ago |
| SMA: Bullish | Jun 2, 2025 | 1 year ago |
| SMA: Bearish | May 19, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| SMA: Bearish | Mar 31, 2025 | 1 year ago |
| SMA: Bullish | Mar 17, 2025 | 1 year ago |
| SMA: Bearish | Mar 3, 2025 | 1 year ago |
| SMA: Bearish | Feb 24, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 17, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 3, 2025 | 1 year ago |
| RSI: Overbought | Feb 3, 2025 | 1 year ago |
| SMA: Bullish | Jan 13, 2025 | 1 year ago |
| SMA: Bearish | Dec 16, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 16, 2024 | 1 year ago |
| MACD: Buy Signal | Nov 4, 2024 | 1 year ago |
| SMA: Bullish | Oct 28, 2024 | 2 years ago |
| RSI: Overbought | Oct 28, 2024 | 2 years ago |
| SMA: Bearish | Oct 21, 2024 | 2 years ago |
| MACD: Sell Signal | Oct 21, 2024 | 2 years ago |
| SMA: Bullish | Oct 14, 2024 | 2 years ago |
| SMA: Bearish | Oct 7, 2024 | 2 years ago |
| RSI: Overbought | Jul 29, 2024 | 2 years ago |
| MACD: Buy Signal | May 6, 2024 | 2 years ago |
| SMA: Bullish | Apr 29, 2024 | 2 years ago |
| SMA: Bullish | Apr 22, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
| SMA: Bullish | Mar 25, 2024 | 2 years ago |
| SMA: Bearish | Mar 11, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 11, 2024 | 2 years ago |
| SMA: Bearish | Feb 26, 2024 | 2 years ago |
| SMA: Bullish | Dec 18, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 6, 2023 | 2 years ago |
| SMA: Bullish | Oct 23, 2023 | 3 years ago |
| SMA: Bearish | Oct 2, 2023 | 3 years ago |
| SMA: Bullish | Sep 25, 2023 | 3 years ago |
| SMA: Bearish | Jul 24, 2023 | 3 years ago |
| SMA: Bearish | Jul 17, 2023 | 3 years ago |
| SMA: Bullish | Jul 10, 2023 | 3 years ago |
| SMA: Bearish | Jul 3, 2023 | 3 years ago |
| MACD: Sell Signal | Jul 3, 2023 | 3 years ago |
| SMA: Bullish | Jun 26, 2023 | 3 years ago |
| SMA: Bearish | Jun 19, 2023 | 3 years ago |
| RSI: Overbought | Apr 24, 2023 | 3 years ago |
| MACD: Buy Signal | Apr 10, 2023 | 3 years ago |
| SMA: Bullish | Mar 20, 2023 | 3 years ago |
| SMA: Bearish | Feb 6, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 6, 2023 | 3 years ago |
| SMA: Bullish | Jan 30, 2023 | 3 years ago |
| SMA: Bearish | Jan 9, 2023 | 3 years ago |
| SMA: Bullish | Oct 24, 2022 | 4 years ago |
| MACD: Buy Signal | Oct 24, 2022 | 4 years ago |
| SMA: Bullish | Oct 17, 2022 | 4 years ago |
| MACD: Sell Signal | Sep 26, 2022 | 4 years ago |
| SMA: Bearish | Sep 12, 2022 | 4 years ago |
| SMA: Bearish | Sep 12, 2022 | 4 years ago |
| SMA: Bullish | Sep 5, 2022 | 4 years ago |
| SMA: Bearish | Aug 15, 2022 | 4 years ago |
| MACD: Buy Signal | Aug 8, 2022 | 4 years ago |
| SMA: Bullish | Aug 1, 2022 | 4 years ago |
| SMA: Bullish | Jul 25, 2022 | 4 years ago |
| SMA: Bearish | Apr 25, 2022 | 4 years ago |
| SMA: Bullish | Feb 21, 2022 | 4 years ago |
Key statistics
- Market cap
- 5.05B
- Enterprise value
- 5.49B
- Trailing P/E
- 31.58
- Forward P/E
- 18.06
- PEG ratio
- 1.56
- Price / sales
- 3.14
- Price / book
- 2.89
- EPS (TTM)
- 2.67
- Beta
- 0.55
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 9.94%
- Revenue (TTM)
- 1.61B
- Revenue growth
- 8.40%
- Free cash flow
- 170.94M
- Total cash
- 503.55M
- Total debt
- 822.06M
- Return on equity
- 9.78%
- Shares outstanding
- 59.92M
- Short % of float
- 8.55%
- 50-day average
- 88.60
- 200-day average
- 76.94
Analyst view
Consensus: buy
- Target (low)
- 90.00
- Target (mean)
- 107.00
- Target (high)
- 123.00
- Strong buy5
- Buy4
- Hold3
- Sell0
- Strong sell0
Next earnings
Feb 23, 2027
Expected Feb 23, 2027. Consensus EPS estimate 1.11.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 23, 2027 | Dec 30, 2026 | 1.12 | — | — | — |
| Oct 29, 2026 | Sep 30, 2026 | 1.04 | 1.12 | +0.08 | +7.69% |
| Jul 30, 2026 | Jun 30, 2026 | 0.959 | 1.19 | +0.23 | +24.09% |
| Apr 30, 2026 | Mar 31, 2026 | 0.84 | 0.94 | +0.10 | +11.90% |
| Feb 24, 2026 | Dec 31, 2025 | 0.96 | 1.04 | +0.08 | +8.33% |
| Oct 30, 2025 | Sep 30, 2025 | 0.82 | 0.92 | +0.10 | +12.20% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | Canaccord Genuity | main | Buy | Buy |
| Oct 30, 2026 | JP Morgan | main | Overweight | Overweight |
| Oct 30, 2026 | Wells Fargo | main | Equal-Weight | Equal-Weight |
| Oct 30, 2026 | Needham | main | Buy | Buy |
| Oct 30, 2026 | BTIG | main | Buy | Buy |
| Oct 27, 2026 | Freedom Capital Markets | init | — | Hold |
About Merit Medical Systems, Inc.
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; kits and accessories for endoscopy and bronchoscopy procedures; and temporary pacing technology. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- merit.com
News
- Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $121
- JP Morgan Maintains Overweight on Merit Medical Systems, Raises Price Target to $110
- Wells Fargo Maintains Equal-Weight on Merit Medical Systems, Raises Price Target to $92
- These Analysts Boost Their Forecasts On Merit Medical Systems After Strong Q3 Results
- These Analysts Boost Their Forecasts On Merit Medical Systems After Strong Q3 Results
- Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $106
- BTIG Maintains Buy on Merit Medical Systems, Raises Price Target to $110
- Merit Medical Systems, Inc. (MMSI) Q3 2026 Earnings Call Transcript
- Merit Medical Systems Q3 Earnings Call Highlights
- Merit Medical (MMSI) Q3 Earnings and Revenues Beat Estimates
Your note
Sign in to keep a note on MMSI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ARONSON MARTHA GOLDBERG | Chief Executive Officer | Purchase | May 5, 2026 | 49,792 |
| CARPENTER LONNY J | Director | Stock Award(Grant) | May 17, 2026 | 20,824 |
| GUNDERSON THOMAS JAMES | Director | Conversion of Exercise of derivative security | May 19, 2026 | 60,741 |
| LAMPROPOULOS FRED P | Officer and Director | Sale | Nov 24, 2025 | 1,126,460 |
| LLOYD BRIAN G | Officer | Stock Gift | Jun 4, 2026 | 62,132 |
| MILLNER F ANN | Director | Stock Award(Grant) | May 17, 2026 | 38,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 15.80% | 9,464,542 | 797.96M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.80% | 3,473,833 | 292.88M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.32% | 2,590,454 | 218.40M | Jun 29, 2026 |
| State Street Corporation | 4.13% | 2,474,512 | 208.63M | Jun 29, 2026 |
| Conestoga Capital Advisors, LLC | 3.30% | 1,979,790 | 166.92M | Jun 29, 2026 |
| Geode Capital Management, LLC | 2.71% | 1,625,950 | 137.08M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.94% | 3,556,402 | 299.84M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.01% | 1,802,360 | 151.96M | Jun 29, 2026 |
| Capitol Series Trust-FullerThaler Behavioral Small-Cap Equity Fund | 2.58% | 1,543,773 | 130.16M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.57% | 1,542,648 | 130.06M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.17% | 1,299,239 | 109.54M | Jun 29, 2026 |
| Conestoga Funds-Conestoga Small Cap Fund | 1.60% | 958,075 | 80.78M | Jun 29, 2026 |